Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia

Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia: "Ranbaxy Laboratories Limited (RLL), announced today that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg."